Calcium Carbonate PDE report and OEL report profile
Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.
CAS Registry Number
471-34-1
Molecular formula
CCaO3
Molecular weight
100.09 g/mol
Drug class
Inorganic calcium saltcalcium supplement, antacid and phosphate-binding agent
Mechanism of action
Dissociates in the gastrointestinal tract to provide calcium ions. Calcium carbonate neutralises gastric hydrochloric acid and, in the intestine, binds phosphate to form poorly absorbed calcium-phosphate complexes; the product formulation and administration with food determine its use.
Indications / reported uses
Calcium supplementation and prevention or treatment of inadequate calcium intake
Symptomatic relief of acid-related dyspepsia and heartburn in authorised antacid formulations
Phosphate binding in selected patients with chronic kidney disease where specifically authorised; monitor calcium and phosphate balance
Scope is agreed for the exact substance form, intended use, exposure route, workplace context and available toxicological evidence.
PDE/ADE: critical effects, point of departure and justified adjustment factors.
OEL: inhalation hazards, exposure duration and workplace conditions.
OEB/OHC: evidence-based banding where requested; a band is not a numerical OEL.
Report: scientific rationale, source data, assumptions, uncertainties and limitations.
Assessment scope
PDE/ADE and OEL/OEB assessment
ReguSight provides project-specific support for Calcium Carbonate PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Calcium Carbonate Permitted Daily Exposure (PDE) report (the Calcium Carbonate PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Calcium Carbonate Occupational Exposure Limit (OEL) report (the Calcium Carbonate OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.
Assessment may cover
PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.